Correlation Between Zura Bio and Agios Pharm

Can any of the company-specific risk be diversified away by investing in both Zura Bio and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zura Bio Limited and Agios Pharm, you can compare the effects of market volatilities on Zura Bio and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Agios Pharm.

Diversification Opportunities for Zura Bio and Agios Pharm

-0.45

Correlation Coefficient

Zura Bio  Agios Pharm

Very good diversification

The 3 months correlation between Zura and Agios is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Zura Bio i.e., Zura Bio and Agios Pharm go up and down completely randomly.

Pair Corralation between Zura Bio and Agios Pharm

Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Agios Pharm. In addition to that, Zura Bio is 1.22 times more volatile than Agios Pharm. It trades about -0.06 of its total potential returns per unit of risk. Agios Pharm is currently generating about -0.01 per unit of volatility. If you would invest  4,669  in Agios Pharm on September 13, 2024 and sell it today you would lose (332.00) from holding Agios Pharm or give up 7.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Zura Bio Limited  vs.  Agios Pharm

Zura Bio Limited

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Agios Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Agios Pharm is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Zura Bio and Agios Pharm

The main advantage of trading using opposite Zura Bio and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.

The idea behind Zura Bio Limited and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..